Meeder Asset Management Inc Adaptive Biotechnologies Corp Transaction History

Meeder Asset Management Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$6.26 - $9.34 $28,313 - $42,244	4,523 Added 407.84%	5,632 $43,000
Q3 2022 Nov 14, 2022	BUY	$6.5 - $12.67 $3,393 - $6,613	522 Added 88.93%	1,109 $8,000
Q2 2022 Aug 08, 2022	BUY	$6.4 - $14.73 $1,875 - $4,315	293 Added 99.66%	587 $5,000
Q1 2022 May 10, 2022	BUY	$10.12 - $28.9 $2,975 - $8,496	294 New	294 $4,000
Q4 2021 Feb 11, 2022	SELL	$25.17 - $36.85 $830 - $1,216	-33 Closed	0 $0
Q3 2021 Nov 08, 2021	SELL	$30.02 - $39.87 $210 - $279	-7 Reduced 17.5%	33 $1,000
Q3 2020 Nov 02, 2020	SELL	$35.79 - $48.81 $286 - $390	-8 Reduced 16.67%	40 $2,000
Q2 2020 Aug 11, 2020	SELL	$24.95 - $48.38 $449 - $870	-18 Reduced 27.27%	48 $2,000
Q1 2020 May 15, 2020	BUY	$16.96 - $34.16 $1,017 - $2,049	60 Added 1000.0%	66 $2,000
Q4 2019 Feb 13, 2020	BUY	$24.56 - $32.8 $147 - $196	6 New	6 $0

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.